Segundo, Mark S.
HRN: 23-34-50 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/14/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/14/2023
08/21/2023
IV
175mg
Q6hours
Neonatal Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes